Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

27 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Immunomodulatory effects of anti-angiogenic drugs.
Heine A, Held SA, Bringmann A, Holderried TA, Brossart P. Heine A, et al. Among authors: holderried ta. Leukemia. 2011 Jun;25(6):899-905. doi: 10.1038/leu.2011.24. Epub 2011 Feb 25. Leukemia. 2011. PMID: 21350557 Review.
Characterization of BAX inhibitor-1 as a novel leukemia-associated antigen.
Schmidt SM, König T, Bringmann A, Held S, von Schwarzenberg K, Heine A, Holderried TA, Stevanovic S, Grünebach F, Brossart P. Schmidt SM, et al. Among authors: holderried ta. Leukemia. 2009 Oct;23(10):1818-24. doi: 10.1038/leu.2009.138. Epub 2009 Jul 16. Leukemia. 2009. PMID: 19609282
Immunotherapy in renal cell carcinoma.
Heine A, Holderried TA, Brossart P. Heine A, et al. Among authors: holderried ta. Immunotherapy. 2009 Jan;1(1):97-107. doi: 10.2217/1750743X.1.1.97. Immunotherapy. 2009. PMID: 20635977 Review.
Intradermal vaccinations with RNA coding for TAA generate CD8+ and CD4+ immune responses and induce clinical benefit in vaccinated patients.
Rittig SM, Haentschel M, Weimer KJ, Heine A, Muller MR, Brugger W, Horger MS, Maksimovic O, Stenzl A, Hoerr I, Rammensee HG, Holderried TA, Kanz L, Pascolo S, Brossart P. Rittig SM, et al. Among authors: holderried ta. Mol Ther. 2011 May;19(5):990-9. doi: 10.1038/mt.2010.289. Epub 2010 Dec 28. Mol Ther. 2011. PMID: 21189474 Free PMC article. Clinical Trial.
27 results